USANA Health Sciences, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

FAIR VALUE MEASURES (Tables)

FAIR VALUE MEASURES (Tables)

6 Months Ended

Jul. 04, 2026

Schedule Of Assets And Liabilities Measured At Fair Value

As of July 4, 2026 and January 3, 2026, the following financial assets and liabilities were measured at fair value on a recurring basis using the type of inputs shown:


	July 4, 2026		Fair value measurements using
			Inputs
			Level 1		Level 2		Level 3
Money market funds included in cash equivalents	$	103,109	$	103,109	$	—	$	—
Foreign currency contracts included in other current liabilities	(26)		—		(26)		—

Deferred compensation liabilities included in other long-term liabilities	(6,465)		—		(6,465)		—


	January 3, 2026		Fair value measurements using
			Inputs
			Level 1		Level 2		Level 3
Money market funds included in cash equivalents	$	87,851	$	87,851	$	—	$	—
Foreign currency contracts included in other current liabilities	(26)		—		(26)		—
Deferred compensation liabilities included in other long-term liabilities	(6,024)		—		(6,024)		—